Atlas Trials

Immunotherapy in Lung Cancer: Treatment After IO Cessation.

Clinical trial NCT04465942 · UNKNOWN

Trial details

NCT number
NCT04465942
Sponsor
European Lung Cancer Working Party
Status
UNKNOWN
Study type
OBSERVATIONAL
Carcinoma, Non-Small-Cell LungImmunotherapy
Start date
2020-06-26
Primary completion
2024-06-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.